☆ 4.5 Article

ROTACs leverage signaling-incompetent R-spondin for targeted protein degradation

CELL CHEMICAL BIOLOGY (2023)

相关参考文献

注意：仅列出部分参考文献，下载原文获取全部文献信息。

Article Biotechnology & Applied Microbiology

Modular cytokine receptor-targeting chimeras for targeted degradation of cell surface and extracellular proteins

Katarina Pance et al.

Summary: KineTACs are modular bispecific antibodies that can degrade extracellular and cell-surface proteins. They provide a genetically encoded strategy for lysosomal delivery of target proteins, with broad or tissue-specific distribution. KineTACs offer a versatile and simple approach to modulate extracellular biology.

NATURE BIOTECHNOLOGY (2023)

添加到收藏夹

Article Biochemistry & Molecular Biology

Uncoupling the BMP receptor antagonist function from the WNT agonist function of R-spondin 2 using the inhibitory peptide dendrimer RWd

Hyeyoon Lee et al.

Summary: Bone morphogenetic proteins (BMPs) play important roles in various biological processes, including embryogenesis and disease. Recent studies have found that R-spondin 2 (RSPO2) acts as a BMP receptor antagonist, and a peptide derived from RSPO2 can uncouple BMP antagonist function from WNT agonist function, showing potential for therapeutic development in diseases like acute myeloid leukemia (AML). By using a dendrimer based on this peptide, it is possible to selectively target BMP receptor signaling, reduce cell growth, and induce differentiation in AML cells, as well as modulate embryonic patterning in Xenopus embryos.

JOURNAL OF BIOLOGICAL CHEMISTRY (2022)

添加到收藏夹

Review Biotechnology & Applied Microbiology

PROTAC targeted protein degraders: the past is prologue

Miklos Bekes et al.

Summary: Targeted protein degradation (TPD) is a new therapeutic modality that can tackle disease-causing proteins which are difficult to target with conventional small molecules. PROTAC molecules, utilizing the ubiquitin-proteasome system to degrade target proteins, has achieved clinical proof-of-concept and attracted significant industry activity. Future directions include identifying target classes suitable for TPD, expanding the use of ubiquitin ligases for precision medicine, and extending the modality beyond oncology.

NATURE REVIEWS DRUG DISCOVERY (2022)

添加到收藏夹

Article Multidisciplinary Sciences

Landscape of helper and regulatory antitumour CD4+ T cells in melanoma

Giacomo Oliveira et al.

Summary: In this study, the phenotype and tumor specificity of CD4 (+) T cells infiltrating human melanoma specimens were analyzed in depth, revealing that melanoma cells can directly induce exhausted cytotoxic CD4 (+) T cells through recognition of HLA class II-restricted neoantigens and HLA class I-restricted tumor-associated antigens. CD4 (+) T regulatory (T-Reg) cells can be indirectly elicited through the presentation of tumor antigens via antigen-presenting cells. Interestingly, a large number of tumor-reactive CD4 (+) T-Reg clones were stimulated directly by HLA class II-positive melanoma and showed specificity for melanoma neoantigens. These findings suggest that the presentation of HLA class II-restricted neoantigens and direct engagement of immunosuppressive CD4 (+) T-Reg cells are favored mechanisms of immune evasion in HLA class II-positive melanoma.

NATURE (2022)

添加到收藏夹

Article Multidisciplinary Sciences

Antibody targeting of E3 ubiquitin ligases for receptor degradation

Hadir Marei et al.

Summary: The study presents a strategy utilizing PROTABs technology to achieve target degradation advantages, enabling tissue-selective degradation of cell-surface receptors. By optimizing antibody formats, this technology can facilitate 'on-demand' degradation.

NATURE (2022)

添加到收藏夹

Review Chemistry, Medicinal

Proteolysis Targeting Chimeras (PROTACs): A Perspective on Integral Membrane Protein Degradation

Camilla Ruffilli et al.

Summary: Targeted protein degradation (TPD) is a promising therapeutic modality, but its application to degrade integral membrane proteins (IMPs) is still in its beginnings. This review discusses the potential reasons for this and presents new tools that have been developed to overcome these limitations and empower the use of PROTACs to target IMPs.

ACS PHARMACOLOGY & TRANSLATIONAL SCIENCE (2022)

添加到收藏夹

Review Chemistry, Multidisciplinary

PROTACs: past, present and future

Ke Li et al.

Summary: PROTACs are a type of molecules with novel event-driven mechanism, offering multiple advantages over traditional inhibitors, such as catalytic nature and targeted protein degradation, which may lead to improved therapeutic outcomes with reduced toxicity. However, further research and development efforts are needed to fully explore their potential.

CHEMICAL SOCIETY REVIEWS (2022)

添加到收藏夹

Review Biochemistry & Molecular Biology

Targeted protein degradation: mechanisms, strategies and application

Lin Zhao et al.

Summary: Traditional drug discovery focuses on direct regulation of protein activity. However, the emerging targeted protein degradation (TPD) technologies, such as PROTAC, provide potential approaches to remove disease-associated proteins by utilizing cells' degradation machinery. These TPD strategies, including molecular glue, LYTAC, and AbTAC, expand the scope of TPD and offer fresh insights into drug discovery.

SIGNAL TRANSDUCTION AND TARGETED THERAPY (2022)

添加到收藏夹

Article Chemistry, Multidisciplinary

Development of Antibody-Based PROTACs for the Degradation of the Cell-Surface Immune Checkpoint Protein PD-L1

Adam D. Cotton et al.

Summary: AbTACs are fully recombinant bispecific antibodies that recruit membrane-bound E3 ligases for the degradation of cell-surface proteins. This new archetype represents a method within the PROTAC field to target cell-surface proteins with fully recombinant biological molecules.

JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2021)

添加到收藏夹

Article Chemistry, Multidisciplinary

Bispecific Aptamer Chimeras Enable Targeted Protein Degradation on Cell Membranes

Yanyan Miao et al.

Summary: This study describes a platform for the targeted degradation of membrane-associated proteins using bispecific aptamer chimeras, which efficiently shuttle therapeutically relevant membrane proteins to lysosomes for degradation. This method provides a universal platform for biochemical research and potential therapeutics using readily synthesized aptamer materials.

ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2021)

添加到收藏夹

Article Chemistry, Multidisciplinary

Covalently Engineered Nanobody Chimeras for Targeted Membrane Protein Degradation

Heng Zhang et al.

Summary: The study introduces a covalent nanobody-based PROTAC strategy named GlueTAC for targeted membrane protein degradation with high specificity and efficiency. By developing a mass-spectrometry-based screening platform, a covalent nanobody (GlueBody) was created for proximity-enabled cross-linking with surface antigens on cancer cells, leading to the internalization and degradation of PD-L1 by the resulting GlueTAC chimera.

JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2021)

添加到收藏夹

Article Chemistry, Multidisciplinary

Development of Triantennary N-Acetylgalactosamine Conjugates as Degraders for Extracellular Proteins

Yaxian Zhou et al.

Summary: Targeted protein degradation (TPD) technology has become a focus of attention for researchers due to its potential as a new therapeutic modality and selective removal of various protein targets. Specifically, LYsosome TArgeting Chimera (LYTAC) has emerged as a promising technology for degrading extracellular protein targets, using the cation-independent mannose-6-phosphate receptor (CI-M6PR) to deliver them to lysosomes. This study successfully utilized the asialoglycoprotein receptor (ASGPR) expressed on liver cells, with the ligand triantennary N-acetylgalactosamine (tri-GalNAc), to target extracellular proteins for degradation, demonstrating cell type specificity in liver cell lines.

ACS CENTRAL SCIENCE (2021)

添加到收藏夹

Article Biology

RNF43 inhibits WNT5A-driven signaling and suppresses melanoma invasion and resistance to the targeted therapy

Tomasz Radaszkiewicz et al.

Summary: RNF43 is not only a negative regulator of WNT/beta-catenin signaling, but also a regulator of noncanonical WNT5A-induced signaling in human cells. It interacts with core receptor complex components of the noncanonical Wnt pathway, triggering ubiquitination and degradation of specific receptors, leading to the suppression of pro-metastatic signaling in melanoma. RNF43 is a negative regulator of WNT5A-mediated responses, desensitizing cells to WNT5A and improving response to targeted therapies in vivo.

ELIFE (2021)

添加到收藏夹

Article Biochemistry & Molecular Biology

LYTACs that engage the asialoglycoprotein receptor for targeted protein degradation

Green Ahn et al.

Summary: Selective protein degradation platforms such as LYTACs provide new opportunities for therapeutic development and biological research. By targeting specific lysosome receptors in a cell-type-specific manner, these LYTACs can efficiently degrade extracellular proteins and hold promise for cell-type-restricted protein degradation strategies.

NATURE CHEMICAL BIOLOGY (2021)

添加到收藏夹

Article Multidisciplinary Sciences

Phenotype, specificity and avidity of antitumour CD8+ T cells in melanoma

Giacomo Oliveira et al.

Summary: The authors demonstrate through single-cell profiling and T cell receptor specificity screening that tumour antigen recognition influences the phenotypes of CD8(+) T cells and antitumour immune responses. Non-tumour-reactive T cells show a non-exhausted memory phenotype, while melanoma-reactive lymphocytes exhibit an exhausted state, providing insights into the properties of the anti-melanoma TCR repertoire.

NATURE (2021)

添加到收藏夹

Article Cell Biology

RSPO2 inhibits BMP signaling to promote self-renewal in acute myeloid leukemia

Rui Sun et al.

Summary: RSPO2 promotes self-renewal of AML cells and may serve as a marker for poor prognosis. It maintains AML self-renewal independently of WNT by inhibiting BMP receptor signaling.

CELL REPORTS (2021)

添加到收藏夹

Review Medicine, Research & Experimental

Emerging protein degradation strategies: expanding the scope to extracellular and membrane proteins

Jiayi Lin et al.

Summary: Protein degradation strategies using PROTACs, LYTACs, and AbTACs have opened up new avenues for targeting previously undruggable proteins. These technologies have expanded the scope of targeting extracellular and membrane proteins, addressing significant medical needs.

THERANOSTICS (2021)

添加到收藏夹

Review Immunology

Challenges and strategies for next-generation bispecific antibody-based antitumor therapeutics

Heliang Li et al.

CELLULAR & MOLECULAR IMMUNOLOGY (2020)

添加到收藏夹

Article Oncology

The Outcome of Ex Vivo TIL Expansion Is Highly Influenced by Spatial Heterogeneity of the Tumor T-Cell Repertoire and Differences in Intrinsic In Vitro Growth Capacity between T-Cell Clones

Isabel C. Poschke et al.

CLINICAL CANCER RESEARCH (2020)

添加到收藏夹

Article Biology

The tumor suppressor PTPRK promotes ZNRF3 internalization and is required for Wnt inhibition in the Spemann organizer

Ling-Shih Chang et al.

ELIFE (2020)

添加到收藏夹

Review Pharmacology & Pharmacy

Emerging New Concepts of Degrader Technologies

Yu Ding et al.

TRENDS IN PHARMACOLOGICAL SCIENCES (2020)

添加到收藏夹

Article Multidisciplinary Sciences

Lysosome-targeting chimaeras for degradation of extracellular proteins

Steven M. Banik et al.

NATURE (2020)

添加到收藏夹

Article Medicine, General & Internal

Atezolizumab for First-Line Treatment of PD-L1-Selected Patients with NSCLC

Roy S. Herbst et al.

NEW ENGLAND JOURNAL OF MEDICINE (2020)

添加到收藏夹

Review Multidisciplinary Sciences

Revisiting the PD-1 pathway

Nikolaos Patsoukis et al.

SCIENCE ADVANCES (2020)

添加到收藏夹

Article Multidisciplinary Sciences

R-spondins are BMP receptor antagonists in Xenopus early embryonic development

Hyeyoon Lee et al.

NATURE COMMUNICATIONS (2020)

添加到收藏夹

Review Immunology

Inhibitory receptors and ligands beyond PD-1, PD-L1 and CTLA-4: breakthroughs or backups

Lawrence P. Andrews et al.

NATURE IMMUNOLOGY (2019)

添加到收藏夹

Article Biochemical Research Methods

Single-pot, solid-phase-enhanced sample preparation for proteomics experiments

Christopher S. Hughes et al.

NATURE PROTOCOLS (2019)

添加到收藏夹

Article Biochemistry & Molecular Biology

Differential activities and mechanisms of the four R-spondins in potentiating Wnt/-catenin signaling

Soohyun Park et al.

JOURNAL OF BIOLOGICAL CHEMISTRY (2018)

添加到收藏夹

Article Oncology

PD-L1 expression is mainly regulated by interferon gamma associated with JAK-STAT pathway in gastric cancer

Kousaku Mimura et al.

CANCER SCIENCE (2018)

添加到收藏夹

Article Oncology

Therapeutic Targeting of Tumor-Derived R-Spondin Attenuates β-Catenin Signaling and Tumorigenesis in Multiple Cancer Types

Cecile Chartier et al.

CANCER RESEARCH (2016)

添加到收藏夹

Article Oncology

Dual Faces of IFNγ in Cancer Progression: A Role of PD-L1 Induction in the Determination of Pro- and Antitumor Immunity

Masaki Mandai et al.

CLINICAL CANCER RESEARCH (2016)

添加到收藏夹

Article Multidisciplinary Sciences

Glycosylation and stabilization of programmed death ligand-1 suppresses T-cell activity

Chia-Wei Li et al.

NATURE COMMUNICATIONS (2016)

添加到收藏夹

Review Oncology

Control of Wnt Receptor Turnover by R-spondin-ZNRF3/RNF43 Signaling Module and Its Dysregulation in Cancer

Huai-Xiang Hao et al.

CANCERS (2016)

添加到收藏夹

Article Biochemistry & Molecular Biology

Molecular Role of RNF43 in Canonical and Noncanonical Wnt Signaling

Tadasuke Tsukiyama et al.

MOLECULAR AND CELLULAR BIOLOGY (2015)

添加到收藏夹

Article Multidisciplinary Sciences

Engineering high-affinity PD-1 variants for optimized immunotherapy and immuno-PET imaging

Roy L. Maute et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2015)

添加到收藏夹

Review Cell Biology

The R-spondin/Lgr5/Rnf43 module: regulator of Wnt signal strength

Wim de Lau et al.

GENES & DEVELOPMENT (2014)

添加到收藏夹

Article Biochemical Research Methods

Accurate Proteome-wide Label-free Quantification by Delayed Normalization and Maximal Peptide Ratio Extraction, Termed MaxLFQ

Juergen Cox et al.

MOLECULAR & CELLULAR PROTEOMICS (2014)

添加到收藏夹

Article Biochemistry & Molecular Biology

Mitotic Wnt Signaling Promotes Protein Stabilization and Regulates Cell Size

Sergio P. Acebron et al.

MOLECULAR CELL (2014)

添加到收藏夹

Article Multidisciplinary Sciences

Predictive correlates of response to the anti-PD-L1 antibody MPDL3280A in cancer patients

Roy S. Herbst et al.

NATURE (2014)

添加到收藏夹

Article Multidisciplinary Sciences

Structures of Wnt-Antagonist ZNRF3 and Its Complex with R-Spondin 1 and Implications for Signaling

Weng Chuan Peng et al.

PLOS ONE (2013)

添加到收藏夹

Article Biochemistry & Molecular Biology

Crystal Structures of Lgr4 and Its Complex with R-Spondin1

Kai Xu et al.

STRUCTURE (2013)

添加到收藏夹

Article Multidisciplinary Sciences

Structural and molecular basis of ZNRF3/RNF43 transmembrane ubiquitin ligase inhibition by the Wnt agonist R-spondin

Matthias Zebisch et al.

NATURE COMMUNICATIONS (2013)

添加到收藏夹

Article Cell Biology

Structure of Stem Cell Growth Factor R-spondin 1 in Complex with the Ectodomain of Its Receptor LGR5

Weng Chuan Peng et al.

CELL REPORTS (2013)

添加到收藏夹

Article Multidisciplinary Sciences

Recurrent R-spondin fusions in colon cancer

Somasekar Seshagiri et al.

NATURE (2012)

添加到收藏夹

Article Multidisciplinary Sciences

ZNRF3 promotes Wnt receptor turnover in an R-spondin-sensitive manner

Huai-Xiang Hao et al.

NATURE (2012)

添加到收藏夹

Article Multidisciplinary Sciences

Tumour suppressor RNF43 is a stem-cell E3 ligase that induces endocytosis of Wnt receptors

Bon-Kyoung Koo et al.

NATURE (2012)

添加到收藏夹

Review Oncology

The blockade of immune checkpoints in cancer immunotherapy

Drew M. Pardoll

NATURE REVIEWS CANCER (2012)

添加到收藏夹

Article Biochemistry & Molecular Biology

LGR4 and LGR5 are R-spondin receptors mediating Wnt/β-catenin and Wnt/PCP signalling

Andrei Glinka et al.

EMBO REPORTS (2011)

添加到收藏夹

Article Biochemical Research Methods

Andromeda: A Peptide Search Engine Integrated into the MaxQuant Environment

Juergen Cox et al.

JOURNAL OF PROTEOME RESEARCH (2011)

添加到收藏夹

Article Multidisciplinary Sciences

R-spondins function as ligands of the orphan receptors LGR4 and LGR5 to regulate Wnt/β-catenin signaling

Kendra S. Carmon et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)

添加到收藏夹

Article Cell Biology

Relationship between CD107a expression and cytotoxic activity

Esin Aktas et al.

CELLULAR IMMUNOLOGY (2009)

添加到收藏夹

Article Developmental Biology

The Wnt signaling regulator R-spondin 3 promotes angioblast and vascular development

Olga Kazanskaya et al.

DEVELOPMENT (2008)

添加到收藏夹

Article Biotechnology & Applied Microbiology

MaxQuant enables high peptide identification rates, individualized p.p.b.-range mass accuracies and proteome-wide protein quantification

Juergen Cox et al.

NATURE BIOTECHNOLOGY (2008)

添加到收藏夹

Article Immunology

Gene transfer of tumor-reactive TCR confers both high avidity and tumor reactivity to nonreactive peripheral blood mononuclear cells and tumor-infiltrating lymphocytes

Laura A. Johnson et al.

JOURNAL OF IMMUNOLOGY (2006)

添加到收藏夹

Article Multidisciplinary Sciences

Mitogenic influence of human R-spondin1 on the intestinal epithelium

KA Kim et al.

SCIENCE (2005)

添加到收藏夹

Article Cell Biology

R-spondin2 is a secreted activator of Wnt/β-catenin signaling and is required for Xenopus myogenesis

O Kazanskaya et al.

DEVELOPMENTAL CELL (2004)

添加到收藏夹

Article Biochemistry & Molecular Biology

Blockade of B7-H1 improves myeloid dendritic cell-mediated antitumor immunity

TJ Curiel et al.

NATURE MEDICINE (2003)

添加到收藏夹

Article Chemistry, Analytical

Stop and go extraction tips for matrix-assisted laser desorption/ionization, nanoelectrospray, and LC/MS sample pretreatment in proteomics

J Rappsilber et al.

ANALYTICAL CHEMISTRY (2003)

添加到收藏夹

Article Biochemistry & Molecular Biology

Tumor-associated B7-H1 promotes T-cell apoptosis: A potential mechanism of immune evasion

HD Dong et al.

NATURE MEDICINE (2002)

添加到收藏夹

Article Multidisciplinary Sciences

Molecular cloning of Porimin, a novel cell surface receptor mediating oncotic cell death

FR Ma et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2001)

添加到收藏夹

Article Multidisciplinary Sciences

Significance analysis of microarrays applied to the ionizing radiation response

VG Tusher et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2001)

添加到收藏夹

Article Immunology

PD-L2 is a second ligand for PD-I and inhibits T cell activation

Y Latchman et al.

NATURE IMMUNOLOGY (2001)

添加到收藏夹

© Peeref 2019-2024. All rights reserved.